

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.80739762 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 9.80739762 |
| 3 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 8.94528795 |
| 4 | respiratory electron transport chain (GO:0022904) | 8.12042374 |
| 5 | electron transport chain (GO:0022900) | 7.91618597 |
| 6 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.76444071 |
| 7 | chaperone-mediated protein transport (GO:0072321) | 5.71050227 |
| 8 | viral transcription (GO:0019083) | 5.33091270 |
| 9 | ATP biosynthetic process (GO:0006754) | 5.26117914 |
| 10 | translational termination (GO:0006415) | 5.21713576 |
| 11 | hydrogen ion transmembrane transport (GO:1902600) | 5.16434716 |
| 12 | ribosomal small subunit assembly (GO:0000028) | 5.12465332 |
| 13 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.99944835 |
| 14 | cotranslational protein targeting to membrane (GO:0006613) | 4.98613536 |
| 15 | protein targeting to ER (GO:0045047) | 4.91536079 |
| 16 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.89095233 |
| 17 | inner mitochondrial membrane organization (GO:0007007) | 4.81857852 |
| 18 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.78496267 |
| 19 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.74030723 |
| 20 | protein complex biogenesis (GO:0070271) | 4.68636759 |
| 21 | protein localization to endoplasmic reticulum (GO:0070972) | 4.65815552 |
| 22 | protein neddylation (GO:0045116) | 4.65725318 |
| 23 | proton transport (GO:0015992) | 4.53240737 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.46009146 |
| 25 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.46009146 |
| 26 | NADH dehydrogenase complex assembly (GO:0010257) | 4.46009146 |
| 27 | hydrogen transport (GO:0006818) | 4.45774587 |
| 28 | translational elongation (GO:0006414) | 4.33538051 |
| 29 | oxidative phosphorylation (GO:0006119) | 4.25275779 |
| 30 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.23314274 |
| 31 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.21872089 |
| 32 | ribosomal large subunit biogenesis (GO:0042273) | 4.21372296 |
| 33 | termination of RNA polymerase III transcription (GO:0006386) | 4.17515248 |
| 34 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.17515248 |
| 35 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.16612528 |
| 36 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.16612528 |
| 37 | translation (GO:0006412) | 4.02172002 |
| 38 | cellular protein complex disassembly (GO:0043624) | 4.02158087 |
| 39 | viral life cycle (GO:0019058) | 3.93047500 |
| 40 | maturation of SSU-rRNA (GO:0030490) | 3.92907825 |
| 41 | translational initiation (GO:0006413) | 3.92814068 |
| 42 | neuron cell-cell adhesion (GO:0007158) | 3.91189594 |
| 43 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.78206988 |
| 44 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.77179690 |
| 45 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.72951973 |
| 46 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.71355561 |
| 47 | dopamine transport (GO:0015872) | 3.67293314 |
| 48 | regulation of oxidative phosphorylation (GO:0002082) | 3.66579109 |
| 49 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.62656924 |
| 50 | GTP biosynthetic process (GO:0006183) | 3.59515850 |
| 51 | regulation of protein kinase A signaling (GO:0010738) | 3.44390259 |
| 52 | sequestering of actin monomers (GO:0042989) | 3.44385875 |
| 53 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.43405896 |
| 54 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.38518119 |
| 55 | negative regulation of ligase activity (GO:0051352) | 3.36101552 |
| 56 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.36101552 |
| 57 | cellular component biogenesis (GO:0044085) | 3.31653030 |
| 58 | protein complex disassembly (GO:0043241) | 3.29829518 |
| 59 | protein targeting to membrane (GO:0006612) | 3.28280588 |
| 60 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.25956684 |
| 61 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.25833447 |
| 62 | neuronal action potential propagation (GO:0019227) | 3.25498080 |
| 63 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.24384602 |
| 64 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.24384602 |
| 65 | macromolecular complex disassembly (GO:0032984) | 3.24206541 |
| 66 | regulation of mitochondrial translation (GO:0070129) | 3.24180068 |
| 67 | rRNA modification (GO:0000154) | 3.21281433 |
| 68 | vocalization behavior (GO:0071625) | 3.17779674 |
| 69 | mitochondrial transport (GO:0006839) | 3.16142007 |
| 70 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.14870698 |
| 71 | establishment of integrated proviral latency (GO:0075713) | 3.14569773 |
| 72 | detection of calcium ion (GO:0005513) | 3.14499675 |
| 73 | CENP-A containing nucleosome assembly (GO:0034080) | 3.13825151 |
| 74 | chromatin remodeling at centromere (GO:0031055) | 3.13672298 |
| 75 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.13330864 |
| 76 | regulation of glutamate secretion (GO:0014048) | 3.12149102 |
| 77 | aerobic respiration (GO:0009060) | 3.11858871 |
| 78 | spliceosomal complex assembly (GO:0000245) | 3.11060577 |
| 79 | establishment of protein localization to mitochondrion (GO:0072655) | 3.10862161 |
| 80 | substantia nigra development (GO:0021762) | 3.10774913 |
| 81 | spliceosomal snRNP assembly (GO:0000387) | 3.10645144 |
| 82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.10441806 |
| 83 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.10132421 |
| 84 | synaptic vesicle exocytosis (GO:0016079) | 3.09787899 |
| 85 | protein targeting to mitochondrion (GO:0006626) | 3.05836133 |
| 86 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.05815354 |
| 87 | DNA damage response, detection of DNA damage (GO:0042769) | 3.04729542 |
| 88 | regulation of dopamine metabolic process (GO:0042053) | 3.04206787 |
| 89 | regulation of catecholamine metabolic process (GO:0042069) | 3.04206787 |
| 90 | neuron recognition (GO:0008038) | 3.01637377 |
| 91 | presynaptic membrane assembly (GO:0097105) | 3.01031049 |
| 92 | protein localization to mitochondrion (GO:0070585) | 3.00657880 |
| 93 | generation of precursor metabolites and energy (GO:0006091) | 3.00212158 |
| 94 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98090732 |
| 95 | regulation of cellular respiration (GO:0043457) | 2.98029310 |
| 96 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.97481274 |
| 97 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.97481274 |
| 98 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.97481274 |
| 99 | positive regulation of synapse assembly (GO:0051965) | 2.96678702 |
| 100 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.96469577 |
| 101 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.96469577 |
| 102 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.95605598 |
| 103 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.95488227 |
| 104 | transferrin transport (GO:0033572) | 2.94567596 |
| 105 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.94286681 |
| 106 | pseudouridine synthesis (GO:0001522) | 2.92280188 |
| 107 | organelle disassembly (GO:1903008) | 2.90564552 |
| 108 | cullin deneddylation (GO:0010388) | 2.90255163 |
| 109 | dopamine biosynthetic process (GO:0042416) | 2.88562921 |
| 110 | UTP biosynthetic process (GO:0006228) | 2.87665978 |
| 111 | regulation of cell communication by electrical coupling (GO:0010649) | 2.87556430 |
| 112 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.85583584 |
| 113 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.85583584 |
| 114 | protein localization to synapse (GO:0035418) | 2.85526109 |
| 115 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.84517378 |
| 116 | presynaptic membrane organization (GO:0097090) | 2.84456243 |
| 117 | ribosomal small subunit biogenesis (GO:0042274) | 2.83481412 |
| 118 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.82903962 |
| 119 | positive regulation of ligase activity (GO:0051351) | 2.82414829 |
| 120 | 7-methylguanosine mRNA capping (GO:0006370) | 2.82345386 |
| 121 | peptidyl-histidine modification (GO:0018202) | 2.81661667 |
| 122 | respiratory chain complex IV assembly (GO:0008535) | 2.81104654 |
| 123 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.80125077 |
| 124 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.80125077 |
| 125 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.79093215 |
| 126 | cytochrome complex assembly (GO:0017004) | 2.78477888 |
| 127 | platelet dense granule organization (GO:0060155) | 2.77770310 |
| 128 | histone mRNA metabolic process (GO:0008334) | 2.77303312 |
| 129 | tricarboxylic acid cycle (GO:0006099) | 2.74978571 |
| 130 | behavioral response to cocaine (GO:0048148) | 2.74549526 |
| 131 | glutamate receptor signaling pathway (GO:0007215) | 2.74407460 |
| 132 | protein-cofactor linkage (GO:0018065) | 2.73151359 |
| 133 | intracellular protein transmembrane import (GO:0044743) | 2.72847131 |
| 134 | ferric iron transport (GO:0015682) | 2.71728030 |
| 135 | trivalent inorganic cation transport (GO:0072512) | 2.71728030 |
| 136 | positive regulation of response to oxidative stress (GO:1902884) | 2.70004472 |
| 137 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.70004472 |
| 138 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.69208994 |
| 139 | succinate metabolic process (GO:0006105) | 2.68677691 |
| 140 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.65807352 |
| 141 | regulation of coenzyme metabolic process (GO:0051196) | 2.64922660 |
| 142 | regulation of cofactor metabolic process (GO:0051193) | 2.64922660 |
| 143 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.64291725 |
| 144 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.62334641 |
| 145 | response to histamine (GO:0034776) | 2.61196023 |
| 146 | neuron-neuron synaptic transmission (GO:0007270) | 2.58825866 |
| 147 | protein localization to cilium (GO:0061512) | 2.57420812 |
| 148 | synaptic transmission, dopaminergic (GO:0001963) | 2.54539850 |
| 149 | opioid receptor signaling pathway (GO:0038003) | 2.51784260 |
| 150 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.49668472 |
| 151 | NADH metabolic process (GO:0006734) | 2.48691695 |
| 152 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.48348085 |
| 153 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.48271292 |
| 154 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.48169526 |
| 155 | UTP metabolic process (GO:0046051) | 2.47672247 |
| 156 | transmission of nerve impulse (GO:0019226) | 2.46791953 |
| 157 | purine nucleoside biosynthetic process (GO:0042451) | 2.46108623 |
| 158 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.46108623 |
| 159 | proteasome assembly (GO:0043248) | 2.45830007 |
| 160 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.44715053 |
| 161 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 10.4958850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.40486565 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24132214 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.15365689 |
| 4 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.07267837 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.03568746 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.92599612 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.77450073 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.68669684 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.57022404 |
| 10 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.54993825 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.50505500 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40211893 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.39503882 |
| 14 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.28587787 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27948652 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27241926 |
| 17 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.26595128 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23120647 |
| 19 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.22860352 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.16836842 |
| 21 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.16444801 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14158139 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09296228 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 2.08545892 |
| 25 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.04622261 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.03057800 |
| 27 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01853590 |
| 28 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.01410496 |
| 29 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.99399299 |
| 30 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.98796538 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.97350214 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.96712111 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.95742834 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.91935621 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.91672184 |
| 36 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.91143641 |
| 37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87872022 |
| 38 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87872022 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.86404420 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85380832 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.85050952 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.80987764 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80365182 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79313431 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78713217 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72897710 |
| 47 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.72321341 |
| 48 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70090390 |
| 49 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.69530781 |
| 50 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.68880507 |
| 51 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.67406347 |
| 52 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.65965731 |
| 53 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.65167456 |
| 54 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.61519182 |
| 55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58816672 |
| 56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55140785 |
| 57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54981948 |
| 58 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.54173007 |
| 59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.54060910 |
| 60 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53891036 |
| 61 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53565292 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52539277 |
| 63 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51951532 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.51163717 |
| 65 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49218141 |
| 66 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47276975 |
| 67 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.45324672 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45093499 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43928393 |
| 70 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43037035 |
| 71 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.43020141 |
| 72 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41637079 |
| 73 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.35967620 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34380247 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.32855081 |
| 76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.32773867 |
| 77 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.32638378 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32068193 |
| 79 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31707216 |
| 80 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30697812 |
| 81 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30295524 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27461724 |
| 83 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.27229501 |
| 84 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27116427 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.26004054 |
| 86 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24012029 |
| 87 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24003276 |
| 88 | JUN_21703547_ChIP-Seq_K562_Human | 1.23701257 |
| 89 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.23491924 |
| 90 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.23483774 |
| 91 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.22416261 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21987851 |
| 93 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.21182698 |
| 94 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19348840 |
| 95 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18626723 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17140638 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.16700162 |
| 98 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.15267451 |
| 99 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.15095934 |
| 100 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14922695 |
| 101 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14682840 |
| 102 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.14373215 |
| 103 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11852595 |
| 104 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.11219380 |
| 105 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.10794225 |
| 106 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09980834 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08213800 |
| 108 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07772149 |
| 109 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.07624880 |
| 110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07388796 |
| 111 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07027814 |
| 112 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.06151914 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06116738 |
| 114 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01223601 |
| 115 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.00866436 |
| 116 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98701125 |
| 117 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.97802507 |
| 118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97586844 |
| 119 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97047292 |
| 120 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.96653115 |
| 121 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96307740 |
| 122 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95538050 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95053963 |
| 124 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94905141 |
| 125 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.94838973 |
| 126 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94301849 |
| 127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.93386781 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93202721 |
| 129 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.91236184 |
| 130 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.89877293 |
| 131 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.89751477 |
| 132 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.89291093 |
| 133 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.89036485 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88499178 |
| 135 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86639557 |
| 136 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.86351168 |
| 137 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.86351168 |
| 138 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.82682795 |
| 139 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.82682795 |
| 140 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.80564214 |
| 141 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.80123669 |
| 142 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.78534371 |
| 143 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.78521052 |
| 144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77137305 |
| 145 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77137305 |
| 146 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.77077545 |
| 147 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.76993238 |
| 148 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.72862162 |
| 149 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.72510996 |
| 150 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.71407163 |
| 151 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70790334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.39446985 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.91045655 |
| 3 | MP0001529_abnormal_vocalization | 3.43527496 |
| 4 | MP0006276_abnormal_autonomic_nervous | 3.06305367 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 2.74471024 |
| 6 | MP0001968_abnormal_touch/_nociception | 2.73508549 |
| 7 | MP0009745_abnormal_behavioral_response | 2.70319108 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.67788884 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.62001750 |
| 10 | MP0002736_abnormal_nociception_after | 2.57085408 |
| 11 | MP0002064_seizures | 2.56926088 |
| 12 | MP0009046_muscle_twitch | 2.50510597 |
| 13 | MP0001440_abnormal_grooming_behavior | 2.48538310 |
| 14 | MP0001905_abnormal_dopamine_level | 2.48460234 |
| 15 | MP0003186_abnormal_redox_activity | 2.43356981 |
| 16 | MP0002272_abnormal_nervous_system | 2.29846127 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.28528198 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.25159529 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.21995130 |
| 20 | MP0003011_delayed_dark_adaptation | 2.15838575 |
| 21 | MP0002938_white_spotting | 2.09128034 |
| 22 | MP0004270_analgesia | 2.08024663 |
| 23 | MP0004142_abnormal_muscle_tone | 2.01736032 |
| 24 | MP0000751_myopathy | 2.00294395 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.99147529 |
| 26 | MP0001486_abnormal_startle_reflex | 1.97504759 |
| 27 | MP0002735_abnormal_chemical_nociception | 1.94880654 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.94435243 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.93961227 |
| 30 | MP0005423_abnormal_somatic_nervous | 1.90246546 |
| 31 | MP0008058_abnormal_DNA_repair | 1.86790755 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.82507681 |
| 33 | MP0004924_abnormal_behavior | 1.82507681 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.81714959 |
| 35 | MP0002067_abnormal_sensory_capabilities | 1.78875948 |
| 36 | MP0008877_abnormal_DNA_methylation | 1.77125750 |
| 37 | MP0006035_abnormal_mitochondrial_morpho | 1.74617118 |
| 38 | MP0003646_muscle_fatigue | 1.73197572 |
| 39 | MP0001970_abnormal_pain_threshold | 1.71807936 |
| 40 | MP0001984_abnormal_olfaction | 1.71552151 |
| 41 | MP0002733_abnormal_thermal_nociception | 1.70741055 |
| 42 | MP0003718_maternal_effect | 1.68636554 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.62577809 |
| 44 | MP0004957_abnormal_blastocyst_morpholog | 1.55943014 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.55379265 |
| 46 | MP0002184_abnormal_innervation | 1.53481800 |
| 47 | MP0003122_maternal_imprinting | 1.51532061 |
| 48 | MP0001188_hyperpigmentation | 1.51302123 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.50041846 |
| 50 | MP0002638_abnormal_pupillary_reflex | 1.49517921 |
| 51 | MP0004147_increased_porphyrin_level | 1.47601149 |
| 52 | MP0002163_abnormal_gland_morphology | 1.44292916 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.43929656 |
| 54 | MP0000778_abnormal_nervous_system | 1.42451103 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.41764942 |
| 56 | MP0002822_catalepsy | 1.40685397 |
| 57 | MP0003121_genomic_imprinting | 1.39429312 |
| 58 | MP0001293_anophthalmia | 1.36915246 |
| 59 | MP0005253_abnormal_eye_physiology | 1.35586242 |
| 60 | MP0003329_amyloid_beta_deposits | 1.35137744 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.34755634 |
| 62 | MP0004036_abnormal_muscle_relaxation | 1.34004889 |
| 63 | MP0002557_abnormal_social/conspecific_i | 1.32001826 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.28524797 |
| 65 | MP0004484_altered_response_of | 1.27652224 |
| 66 | MP0003890_abnormal_embryonic-extraembry | 1.25965592 |
| 67 | MP0005535_abnormal_body_temperature | 1.24836580 |
| 68 | MP0002090_abnormal_vision | 1.23567471 |
| 69 | MP0003137_abnormal_impulse_conducting | 1.23338113 |
| 70 | MP0004742_abnormal_vestibular_system | 1.23199513 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.22233295 |
| 72 | MP0006072_abnormal_retinal_apoptosis | 1.22058286 |
| 73 | MP0003941_abnormal_skin_development | 1.20948594 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 1.20523982 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.19467476 |
| 76 | MP0004133_heterotaxia | 1.19459574 |
| 77 | MP0009697_abnormal_copulation | 1.18294782 |
| 78 | MP0003136_yellow_coat_color | 1.17535015 |
| 79 | MP0005409_darkened_coat_color | 1.17257150 |
| 80 | MP0003123_paternal_imprinting | 1.16470864 |
| 81 | MP0008995_early_reproductive_senescence | 1.15022428 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 1.13670861 |
| 83 | MP0004085_abnormal_heartbeat | 1.13546922 |
| 84 | MP0003786_premature_aging | 1.13148190 |
| 85 | MP0001727_abnormal_embryo_implantation | 1.12893101 |
| 86 | MP0002160_abnormal_reproductive_system | 1.11922169 |
| 87 | MP0008875_abnormal_xenobiotic_pharmacok | 1.10378187 |
| 88 | MP0001502_abnormal_circadian_rhythm | 1.09008336 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 1.08807488 |
| 90 | MP0003693_abnormal_embryo_hatching | 1.08525899 |
| 91 | MP0003787_abnormal_imprinting | 1.08433118 |
| 92 | MP0000749_muscle_degeneration | 1.08414532 |
| 93 | MP0005332_abnormal_amino_acid | 1.00676854 |
| 94 | MP0005646_abnormal_pituitary_gland | 0.98889579 |
| 95 | MP0008872_abnormal_physiological_respon | 0.98230409 |
| 96 | MP0002882_abnormal_neuron_morphology | 0.98076150 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.97828298 |
| 98 | MP0005330_cardiomyopathy | 0.97433893 |
| 99 | MP0003315_abnormal_perineum_morphology | 0.97193419 |
| 100 | MP0004043_abnormal_pH_regulation | 0.96933364 |
| 101 | MP0002234_abnormal_pharynx_morphology | 0.96449148 |
| 102 | MP0004084_abnormal_cardiac_muscle | 0.96325747 |
| 103 | MP0005389_reproductive_system_phenotype | 0.95239078 |
| 104 | MP0010094_abnormal_chromosome_stability | 0.95197401 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.95159653 |
| 106 | MP0002751_abnormal_autonomic_nervous | 0.95100602 |
| 107 | MP0003195_calcinosis | 0.94385538 |
| 108 | MP0005408_hypopigmentation | 0.93492064 |
| 109 | MP0005171_absent_coat_pigmentation | 0.92114364 |
| 110 | MP0005620_abnormal_muscle_contractility | 0.92086264 |
| 111 | MP0001764_abnormal_homeostasis | 0.89883308 |
| 112 | MP0000049_abnormal_middle_ear | 0.89563277 |
| 113 | MP0001963_abnormal_hearing_physiology | 0.88521239 |
| 114 | MP0002210_abnormal_sex_determination | 0.87076130 |
| 115 | MP0000955_abnormal_spinal_cord | 0.86920827 |
| 116 | MP0001919_abnormal_reproductive_system | 0.85763670 |
| 117 | MP0002229_neurodegeneration | 0.85643535 |
| 118 | MP0006292_abnormal_olfactory_placode | 0.84517897 |
| 119 | MP0002909_abnormal_adrenal_gland | 0.83718527 |
| 120 | MP0008932_abnormal_embryonic_tissue | 0.83224416 |
| 121 | MP0008569_lethality_at_weaning | 0.82101222 |
| 122 | MP0001664_abnormal_digestion | 0.81259053 |
| 123 | MP0003938_abnormal_ear_development | 0.80735774 |
| 124 | MP0005195_abnormal_posterior_eye | 0.80240332 |
| 125 | MP0000631_abnormal_neuroendocrine_gland | 0.79956113 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.79850553 |
| 127 | MP0003077_abnormal_cell_cycle | 0.79691876 |
| 128 | MP0010030_abnormal_orbit_morphology | 0.79518854 |
| 129 | MP0002106_abnormal_muscle_physiology | 0.78220192 |
| 130 | MP0003879_abnormal_hair_cell | 0.77840491 |
| 131 | MP0000026_abnormal_inner_ear | 0.77527712 |
| 132 | MP0002102_abnormal_ear_morphology | 0.75949508 |
| 133 | MP0005499_abnormal_olfactory_system | 0.74492501 |
| 134 | MP0005394_taste/olfaction_phenotype | 0.74492501 |
| 135 | MP0004811_abnormal_neuron_physiology | 0.71400562 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.70938272 |
| 137 | MP0000372_irregular_coat_pigmentation | 0.70190251 |
| 138 | MP0000747_muscle_weakness | 0.68946524 |
| 139 | MP0001986_abnormal_taste_sensitivity | 0.68265970 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.67693559 |
| 141 | MP0005369_muscle_phenotype | 0.66597242 |
| 142 | MP0002069_abnormal_eating/drinking_beha | 0.65061491 |
| 143 | MP0008789_abnormal_olfactory_epithelium | 0.64206544 |
| 144 | MP0000920_abnormal_myelination | 0.63748982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.81999937 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 7.09921771 |
| 3 | Progressive macrocephaly (HP:0004481) | 6.77360066 |
| 4 | Mitochondrial inheritance (HP:0001427) | 6.62535727 |
| 5 | Acute encephalopathy (HP:0006846) | 6.39363699 |
| 6 | Increased CSF lactate (HP:0002490) | 5.61107513 |
| 7 | Increased hepatocellular lipid droplets (HP:0006565) | 5.36622825 |
| 8 | Hepatocellular necrosis (HP:0001404) | 5.15798661 |
| 9 | Lipid accumulation in hepatocytes (HP:0006561) | 4.83381431 |
| 10 | Cerebral edema (HP:0002181) | 4.59037357 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 4.54450475 |
| 12 | Hepatic necrosis (HP:0002605) | 4.42610264 |
| 13 | Optic disc pallor (HP:0000543) | 4.20484381 |
| 14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.19532639 |
| 15 | Increased intramyocellular lipid droplets (HP:0012240) | 4.15253812 |
| 16 | Focal motor seizures (HP:0011153) | 4.10034458 |
| 17 | Exercise intolerance (HP:0003546) | 3.99117782 |
| 18 | Respiratory failure (HP:0002878) | 3.82176405 |
| 19 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.75214546 |
| 20 | Lactic acidosis (HP:0003128) | 3.72528308 |
| 21 | Congenital, generalized hypertrichosis (HP:0004540) | 3.69863537 |
| 22 | Leukodystrophy (HP:0002415) | 3.66918085 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.56920574 |
| 24 | Abnormality of glycolysis (HP:0004366) | 3.56920574 |
| 25 | Increased muscle lipid content (HP:0009058) | 3.52753807 |
| 26 | Macrocytic anemia (HP:0001972) | 3.36535745 |
| 27 | Exertional dyspnea (HP:0002875) | 3.29655524 |
| 28 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.24427614 |
| 29 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.24427614 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 3.13004819 |
| 31 | Increased serum lactate (HP:0002151) | 3.10931629 |
| 32 | Reticulocytopenia (HP:0001896) | 3.06660278 |
| 33 | Abnormality of renal resorption (HP:0011038) | 3.02395312 |
| 34 | Pheochromocytoma (HP:0002666) | 2.99212876 |
| 35 | X-linked dominant inheritance (HP:0001423) | 2.98604264 |
| 36 | Neuroendocrine neoplasm (HP:0100634) | 2.93551889 |
| 37 | Atonic seizures (HP:0010819) | 2.92970480 |
| 38 | Respiratory difficulties (HP:0002880) | 2.92390262 |
| 39 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.86346704 |
| 40 | Myokymia (HP:0002411) | 2.79219264 |
| 41 | Visual hallucinations (HP:0002367) | 2.67169052 |
| 42 | Absence seizures (HP:0002121) | 2.65310710 |
| 43 | Methylmalonic acidemia (HP:0002912) | 2.61643036 |
| 44 | Hyperphosphaturia (HP:0003109) | 2.55296050 |
| 45 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.54989106 |
| 46 | Focal seizures (HP:0007359) | 2.54680698 |
| 47 | Hyperventilation (HP:0002883) | 2.47202579 |
| 48 | Epileptic encephalopathy (HP:0200134) | 2.46120826 |
| 49 | Dialeptic seizures (HP:0011146) | 2.45617553 |
| 50 | Oral leukoplakia (HP:0002745) | 2.43745647 |
| 51 | Septo-optic dysplasia (HP:0100842) | 2.42467962 |
| 52 | Aplastic anemia (HP:0001915) | 2.42018109 |
| 53 | Calf muscle hypertrophy (HP:0008981) | 2.32488137 |
| 54 | Methylmalonic aciduria (HP:0012120) | 2.28255965 |
| 55 | Glycosuria (HP:0003076) | 2.27501251 |
| 56 | Abnormality of urine glucose concentration (HP:0011016) | 2.27501251 |
| 57 | Emotional lability (HP:0000712) | 2.26767469 |
| 58 | Pancreatic fibrosis (HP:0100732) | 2.25356940 |
| 59 | Sudden death (HP:0001699) | 2.25224572 |
| 60 | Anxiety (HP:0000739) | 2.23361003 |
| 61 | Limb dystonia (HP:0002451) | 2.21045833 |
| 62 | Pallor (HP:0000980) | 2.20791908 |
| 63 | CNS demyelination (HP:0007305) | 2.20505811 |
| 64 | Medial flaring of the eyebrow (HP:0010747) | 2.20166009 |
| 65 | Parakeratosis (HP:0001036) | 2.14786905 |
| 66 | Pancreatic cysts (HP:0001737) | 2.14402689 |
| 67 | Febrile seizures (HP:0002373) | 2.14283037 |
| 68 | Generalized aminoaciduria (HP:0002909) | 2.13078848 |
| 69 | Abnormal ciliary motility (HP:0012262) | 2.11979633 |
| 70 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.11466019 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.10563500 |
| 72 | Molar tooth sign on MRI (HP:0002419) | 2.10563500 |
| 73 | Abnormal urine phosphate concentration (HP:0012599) | 2.10280040 |
| 74 | Generalized tonic-clonic seizures (HP:0002069) | 2.08179112 |
| 75 | Lethargy (HP:0001254) | 2.07005887 |
| 76 | Gait imbalance (HP:0002141) | 2.06888123 |
| 77 | Progressive inability to walk (HP:0002505) | 2.06031560 |
| 78 | Conjunctival hamartoma (HP:0100780) | 2.04482431 |
| 79 | Amblyopia (HP:0000646) | 2.03596042 |
| 80 | Hyperglycinemia (HP:0002154) | 2.02066817 |
| 81 | Abnormal pupillary function (HP:0007686) | 2.02007658 |
| 82 | Cerebral hemorrhage (HP:0001342) | 2.00699088 |
| 83 | Broad-based gait (HP:0002136) | 1.99004153 |
| 84 | True hermaphroditism (HP:0010459) | 1.98956431 |
| 85 | Type I transferrin isoform profile (HP:0003642) | 1.98846231 |
| 86 | Delusions (HP:0000746) | 1.97016934 |
| 87 | Congenital primary aphakia (HP:0007707) | 1.93336028 |
| 88 | Abnormality of the labia minora (HP:0012880) | 1.92580356 |
| 89 | Colon cancer (HP:0003003) | 1.90772914 |
| 90 | Sclerocornea (HP:0000647) | 1.87380270 |
| 91 | Renal tubular dysfunction (HP:0000124) | 1.86076682 |
| 92 | Abnormality of alanine metabolism (HP:0010916) | 1.85775232 |
| 93 | Hyperalaninemia (HP:0003348) | 1.85775232 |
| 94 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85775232 |
| 95 | Abnormality of serum amino acid levels (HP:0003112) | 1.84286476 |
| 96 | Absent septum pellucidum (HP:0001331) | 1.81695546 |
| 97 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.81317313 |
| 98 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.81317313 |
| 99 | Hypothermia (HP:0002045) | 1.78950981 |
| 100 | Abnormality of the anterior horn cell (HP:0006802) | 1.78878132 |
| 101 | Degeneration of anterior horn cells (HP:0002398) | 1.78878132 |
| 102 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78121745 |
| 103 | Abnormality of methionine metabolism (HP:0010901) | 1.77504673 |
| 104 | Palpitations (HP:0001962) | 1.77353228 |
| 105 | Abnormal number of erythroid precursors (HP:0012131) | 1.73074427 |
| 106 | Stenosis of the external auditory canal (HP:0000402) | 1.72800780 |
| 107 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.72668371 |
| 108 | Retinal dysplasia (HP:0007973) | 1.72615073 |
| 109 | Inability to walk (HP:0002540) | 1.71484953 |
| 110 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.70561237 |
| 111 | Gliosis (HP:0002171) | 1.68712897 |
| 112 | Cerebral inclusion bodies (HP:0100314) | 1.67706603 |
| 113 | Progressive external ophthalmoplegia (HP:0000590) | 1.66667602 |
| 114 | Delayed gross motor development (HP:0002194) | 1.66644209 |
| 115 | Reduced antithrombin III activity (HP:0001976) | 1.65010985 |
| 116 | Blindness (HP:0000618) | 1.64421194 |
| 117 | Polyphagia (HP:0002591) | 1.63700728 |
| 118 | Esotropia (HP:0000565) | 1.63689297 |
| 119 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.63459567 |
| 120 | Vomiting (HP:0002013) | 1.63404451 |
| 121 | Vaginal atresia (HP:0000148) | 1.63346538 |
| 122 | Male pseudohermaphroditism (HP:0000037) | 1.63324028 |
| 123 | Poor suck (HP:0002033) | 1.63307249 |
| 124 | Amniotic constriction ring (HP:0009775) | 1.62453653 |
| 125 | Abnormality of placental membranes (HP:0011409) | 1.62453653 |
| 126 | Genital tract atresia (HP:0001827) | 1.61679833 |
| 127 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.61566478 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 1.61566478 |
| 129 | Rimmed vacuoles (HP:0003805) | 1.60507506 |
| 130 | Syncope (HP:0001279) | 1.59357115 |
| 131 | Abnormality of the calf musculature (HP:0001430) | 1.59241905 |
| 132 | Myotonia (HP:0002486) | 1.59173105 |
| 133 | Nephronophthisis (HP:0000090) | 1.56757371 |
| 134 | Optic nerve hypoplasia (HP:0000609) | 1.56209742 |
| 135 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.54069318 |
| 136 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.50509711 |
| 137 | Pendular nystagmus (HP:0012043) | 1.50247257 |
| 138 | Pancytopenia (HP:0001876) | 1.48492513 |
| 139 | Megaloblastic anemia (HP:0001889) | 1.47644992 |
| 140 | Abnormality of the septum pellucidum (HP:0007375) | 1.47250314 |
| 141 | Cerebral hypomyelination (HP:0006808) | 1.46855284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 4.01095208 |
| 2 | VRK2 | 3.95253517 |
| 3 | NME1 | 3.51461811 |
| 4 | PNCK | 3.45645786 |
| 5 | MAP2K7 | 2.81572728 |
| 6 | CASK | 2.80054307 |
| 7 | RIPK4 | 2.62330089 |
| 8 | MAP3K4 | 2.60655611 |
| 9 | NTRK3 | 2.52834305 |
| 10 | EPHA4 | 2.49561528 |
| 11 | ARAF | 2.48685144 |
| 12 | BUB1 | 2.44536837 |
| 13 | ZAK | 2.28520017 |
| 14 | CDC7 | 2.21525054 |
| 15 | MYLK | 2.11005759 |
| 16 | NEK1 | 2.05397102 |
| 17 | GRK7 | 2.04587679 |
| 18 | GRK5 | 1.95367610 |
| 19 | BMPR2 | 1.82657689 |
| 20 | SRPK1 | 1.80775756 |
| 21 | MUSK | 1.80318417 |
| 22 | MAP2K4 | 1.78381785 |
| 23 | STK39 | 1.76407727 |
| 24 | STK16 | 1.71971449 |
| 25 | PLK2 | 1.69949761 |
| 26 | TNIK | 1.68062233 |
| 27 | MARK1 | 1.64960770 |
| 28 | OXSR1 | 1.61578985 |
| 29 | MST4 | 1.56665533 |
| 30 | TRIM28 | 1.53933519 |
| 31 | WNK4 | 1.51757722 |
| 32 | MINK1 | 1.48955071 |
| 33 | MAP3K9 | 1.46074166 |
| 34 | CDK19 | 1.41588138 |
| 35 | MAP4K2 | 1.40893372 |
| 36 | NME2 | 1.38574708 |
| 37 | TAF1 | 1.36223238 |
| 38 | OBSCN | 1.35867846 |
| 39 | PLK3 | 1.34815924 |
| 40 | NUAK1 | 1.32734171 |
| 41 | FGR | 1.31854243 |
| 42 | CAMK2A | 1.29950510 |
| 43 | BCR | 1.29357549 |
| 44 | ADRBK2 | 1.28818846 |
| 45 | PLK4 | 1.25008302 |
| 46 | CAMK2B | 1.19580146 |
| 47 | GRK1 | 1.18040511 |
| 48 | WNK3 | 1.18039136 |
| 49 | BMPR1B | 1.14268576 |
| 50 | PBK | 1.14071745 |
| 51 | MAPK13 | 1.13830376 |
| 52 | UHMK1 | 1.12682706 |
| 53 | CAMK2D | 1.09007111 |
| 54 | EIF2AK1 | 1.07788474 |
| 55 | PTK2B | 1.06799049 |
| 56 | BCKDK | 1.05912037 |
| 57 | WEE1 | 1.04415997 |
| 58 | NTRK2 | 1.04233000 |
| 59 | CSNK1G1 | 1.04051736 |
| 60 | DYRK3 | 1.03166691 |
| 61 | MKNK1 | 0.98716235 |
| 62 | ERBB3 | 0.92536711 |
| 63 | ADRBK1 | 0.92048221 |
| 64 | PHKG2 | 0.91012052 |
| 65 | PHKG1 | 0.91012052 |
| 66 | PLK1 | 0.90828708 |
| 67 | PRKCG | 0.90574225 |
| 68 | LIMK1 | 0.90290247 |
| 69 | DAPK1 | 0.88307121 |
| 70 | PRKCE | 0.87885180 |
| 71 | VRK1 | 0.87065537 |
| 72 | MKNK2 | 0.86620829 |
| 73 | BRAF | 0.85604310 |
| 74 | MAPKAPK5 | 0.82942403 |
| 75 | CDK5 | 0.81026683 |
| 76 | TTK | 0.80269545 |
| 77 | CAMK2G | 0.80163580 |
| 78 | GRK6 | 0.79660273 |
| 79 | NTRK1 | 0.78807273 |
| 80 | ABL2 | 0.78392377 |
| 81 | FES | 0.76980158 |
| 82 | PDK3 | 0.76856657 |
| 83 | PDK4 | 0.76856657 |
| 84 | INSRR | 0.75982231 |
| 85 | PAK3 | 0.75360422 |
| 86 | TSSK6 | 0.74590422 |
| 87 | CSNK1A1L | 0.72171561 |
| 88 | AURKB | 0.71913654 |
| 89 | KSR1 | 0.71873675 |
| 90 | CSNK2A2 | 0.71822159 |
| 91 | TESK1 | 0.70524507 |
| 92 | CHEK2 | 0.68366372 |
| 93 | PINK1 | 0.67591627 |
| 94 | ROCK2 | 0.67114257 |
| 95 | RPS6KA5 | 0.66976696 |
| 96 | KSR2 | 0.66619149 |
| 97 | RAF1 | 0.65915810 |
| 98 | DAPK3 | 0.63937742 |
| 99 | PRKACA | 0.63503803 |
| 100 | CSNK2A1 | 0.62819158 |
| 101 | CDK14 | 0.60062427 |
| 102 | AURKA | 0.59132939 |
| 103 | DYRK2 | 0.58346951 |
| 104 | BRSK2 | 0.56988888 |
| 105 | DYRK1A | 0.56976830 |
| 106 | DAPK2 | 0.56717910 |
| 107 | PKN1 | 0.56030325 |
| 108 | PAK4 | 0.55835263 |
| 109 | CDK18 | 0.53435629 |
| 110 | IRAK2 | 0.52553563 |
| 111 | FRK | 0.52205902 |
| 112 | CSNK1E | 0.51795301 |
| 113 | CDK15 | 0.50385023 |
| 114 | MAP3K13 | 0.50101857 |
| 115 | CSNK1G3 | 0.49297987 |
| 116 | TLK1 | 0.48337590 |
| 117 | EIF2AK2 | 0.48119969 |
| 118 | CDK8 | 0.47096159 |
| 119 | CSNK1G2 | 0.46361844 |
| 120 | ILK | 0.46189994 |
| 121 | CDK11A | 0.45832179 |
| 122 | CSNK1A1 | 0.45532521 |
| 123 | EIF2AK3 | 0.45249085 |
| 124 | MAPK12 | 0.45084315 |
| 125 | PDK2 | 0.42793482 |
| 126 | EPHB2 | 0.42277915 |
| 127 | CDK3 | 0.41405431 |
| 128 | PIM2 | 0.40392536 |
| 129 | PIK3CA | 0.40377399 |
| 130 | MOS | 0.38468677 |
| 131 | STK38L | 0.38017978 |
| 132 | MAPK15 | 0.36817219 |
| 133 | PAK6 | 0.36532903 |
| 134 | MAP2K1 | 0.35707286 |
| 135 | PRKCQ | 0.34227454 |
| 136 | MAP3K6 | 0.32792833 |
| 137 | PRKCA | 0.32491818 |
| 138 | CAMK1 | 0.30787111 |
| 139 | PRKG1 | 0.30453868 |
| 140 | PIK3CG | 0.29613118 |
| 141 | LMTK2 | 0.28904076 |
| 142 | CCNB1 | 0.28480116 |
| 143 | CAMKK2 | 0.28322407 |
| 144 | ERBB4 | 0.27570448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.76064584 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.66699907 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 4.53525256 |
| 4 | Huntingtons disease_Homo sapiens_hsa05016 | 4.01793447 |
| 5 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.53148779 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.38257352 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.64324402 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.60395929 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.44745214 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.27534994 |
| 11 | Mismatch repair_Homo sapiens_hsa03430 | 1.99957633 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.94953666 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.88451837 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.87623393 |
| 15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.84870012 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.79148545 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.75995515 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.61531557 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.52899093 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49719349 |
| 21 | DNA replication_Homo sapiens_hsa03030 | 1.49485881 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.44871949 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.41175155 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.37369617 |
| 25 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.35081120 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.34439936 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.31745432 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.29949837 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.27725721 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20012393 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.18877208 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.18540116 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18076429 |
| 34 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17280308 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.13530296 |
| 36 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08119300 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07663234 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.05172056 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02929734 |
| 40 | RNA transport_Homo sapiens_hsa03013 | 0.99863042 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.97676978 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 0.97643779 |
| 43 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94517790 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 0.92510079 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 0.91729867 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90833132 |
| 47 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90614632 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87733051 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.86894462 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86266560 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86256165 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 0.85937623 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84816862 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82530445 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82330832 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.72441071 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72111097 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71455237 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71001201 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 0.70292728 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69014138 |
| 62 | Cocaine addiction_Homo sapiens_hsa05030 | 0.68361619 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.68349387 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67679635 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.66289706 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66088524 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.65704297 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65620629 |
| 69 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65583325 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63463915 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.62448912 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58741408 |
| 73 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.56535114 |
| 74 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55334999 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54301420 |
| 76 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53946573 |
| 77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.53543958 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52137359 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51426697 |
| 80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49483627 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47042329 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.45878716 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45725509 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.45704686 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45054594 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44804962 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44652918 |
| 88 | Phagosome_Homo sapiens_hsa04145 | 0.44250350 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43502429 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43409980 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42708701 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42618362 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42373731 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41214030 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40219923 |
| 96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40091207 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39721185 |
| 98 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.38843736 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38679402 |
| 100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37139107 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35677970 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34692043 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34482661 |
| 104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34012499 |
| 105 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33724763 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33640641 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33528679 |
| 108 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.33159448 |
| 109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32330052 |
| 110 | Cell cycle_Homo sapiens_hsa04110 | 0.32225484 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.32009281 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31873648 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.31567187 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.31351904 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31325623 |
| 116 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30507917 |
| 117 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30435225 |
| 118 | Asthma_Homo sapiens_hsa05310 | 0.30138792 |
| 119 | Alcoholism_Homo sapiens_hsa05034 | 0.30112233 |
| 120 | Axon guidance_Homo sapiens_hsa04360 | 0.29497535 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.28976945 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.28366230 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.28141042 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27502995 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.27472413 |
| 126 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25837158 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.25337149 |
| 128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.25131846 |
| 129 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.22504604 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.21779423 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.18032421 |
| 132 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.15933628 |
| 133 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.14361157 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.13846451 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.13497885 |
| 136 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.13017751 |
| 137 | Peroxisome_Homo sapiens_hsa04146 | 0.12950591 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.12536018 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.11771934 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.10643947 |
| 141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10411213 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10152909 |
| 143 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.09956056 |
| 144 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.09583044 |
| 145 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.09539770 |
| 146 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.09129670 |
| 147 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.08229410 |

